Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 13/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18196886 | 0.87 | ALDH3A1 (0.38) | ALDH3A1HTR6CYP3A4CYP2D6GAA | |
| Hydrochloric Acid SCHEMBL18190940 | 0.86 | ALDH3A1 (0.38) | ALDH3A1HTR6CYP3A4CYP2D6GAA | |
| SCHEMBL18196934 | 0.79 | ALDH3A1 (0.41) | ALDH3A1HTR6GAAKMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL20530222 | 0.78 | ALDH3A1 (0.40) | ALDH3A1HTR6GAAKMT2AALDH1A1 | |
| SCHEMBL28566174 | 0.77 | HTR6 (0.41) | HTR6IDO1KMT2A | |
| Hydrochloric Acid SCHEMBL20530218 | 0.75 | HTR6 (0.39) | HTR6GAAKMT2A | |
| Hydrochloric Acid SCHEMBL20530238 | 0.75 | HTR6 (0.41) | HTR6GAAKMT2AALDH1A1 | |
| SCHEMBL18196924 | 0.74 | HTR6 (0.41) | HTR6CYP3A4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL20530241 | 0.74 | HTR6 (0.41) | HTR6ALDH1A1 | |
| SCHEMBL18196922 | 0.72 | RORC (0.40) | HTR6GAAKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197867-B1 | NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAE WOONG PHARMA (KR) | 2018-11-14 | — | — | EP | claimed |
| US-10100010-B1 | 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2018-10-16 | — | — | US | claimed |
| EP-3197867-B1 | NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAE WOONG PHARMA (KR) | 2018-11-14 | — | — | EP | disclosed |
| US-10100010-B1 | 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2018-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10100010-B1 | 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same | GIPR, GRPR, HTR3E | ALDH3A1 2418/4885HTR6 38/4885IDO1 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.